Netherlands· NL-30ba4abaeaa5

Dipyridamol Glenmark 200 mg, harde capsules met gereguleerde afgifte

A dipyridamole product containing dipyridamol, registered in Netherlands by Glenmark Arzneimittel GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC07

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dipyridamolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dipyridamole is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC07 (dipyridamole), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search dipyridamole products by name

Dipyridamole · ATC B01AC07

11 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Netherlands
Norwayprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DIPYRIDAMOL
Manufacturer: Glenmark Arzneimittel GmbH
Country: Netherlands (NL)
ATC code: B01AC07
ATC class: Dipyridamole
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
122668

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

352 interactions on record for dipyridamole.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dipyridamole against other medicines How interaction checks work

Dipyridamole · interactions on record

352 records

47 severe
93 moderate
5 minor
207 info

Most severe, free to view

DalteparinB01AB04severe
EnoxaparinB01AB05severe
DanaparoidB01AB09severe
TinzaparinB01AB10severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dipyridamole in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dipyridamole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Austria · Persantin
Bulgaria · Антистенокардин, Биокардин
Cyprus · Perazodin, Persantin
Denmark · Dipyridamol Alternova, Dipyridamol Strides
Spain · Persantin
Finland · Persantin
France · Persantine
United Kingdom (Northern Ireland) · Attia, Dipyridamole Dr. Reddy’s
Greece · Persantin
Croatia · Persantin
Ireland · Pyranistole
Iceland · Persantin
Italy · Corosan, Persantin
Malta · Perazodin
Norway · Aponova, Dipyridamol Glenmark
Portugal · Dipiridamol Labesfal, Persantin
Sweden · Dipyridamol Alternova, Pyranistole

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/34495200-54b7-4583-a288-15b7e85edc9a
GET /v1/drugs/34495200-54b7-4583-a288-15b7e85edc9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule met gereguleerde afgifte, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122668_smpc.pdf",
  "strength": null,
  "atc_label": "Dipyridamole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122668",
  "excipients": [
    "AMMONIA (E 527)",
    "ARABISCHE GOM (E 414)",
    "COPOLYMEER VAN METHACRYLZUUR-METHYLMETHACRYLAAT (1:2)(E 1207)",
    "GELATINE (E 441)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "HYPROMELLOSEFTALAAT",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "POVIDON K 30 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)",
    "ZONNEGEEL FCF (E 110)",
    "ZWARTE INKT"
  ],
  "substances": [
    "DIPYRIDAMOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122668.pdf",
  "authorised_at": "2019/02/21",
  "procedure_number": "NL/H/4294/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "122668",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about dipyridamole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console